Breast Cancer Screening: a Paradigm Change Is Needed—the PB Desai Oration

  • Ismail JatoiEmail author
Review Article


This editorial summarizes the key points of the PB Desai Oration, delivered by the author at the National Conference of the Indian Association of Surgical Oncology in Kolkata, India, on September 21, 2019.


Mammography Quality of life Breast cancer Screening 



  1. 1.
    Jatoi I, Anderson WF, Miller AB, Brawley OW (2019) The history of cancer screening. Curr Probl Surg 56(4):138–163CrossRefGoogle Scholar
  2. 2.
    Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690CrossRefGoogle Scholar
  3. 3.
    Loberg M, Lousdal ML, Bretthauer M, Kalager M (2015) Benefits and harms of mammography screening. Breast Cancer Res 17:63CrossRefGoogle Scholar
  4. 4.
    Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ, Clinical Guidelines Committee of the American College of P. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med. 2019Google Scholar
  5. 5.
    Jatoi I, Zhu K, Shah M, Lawrence W (2006) Psychological distress in U.S. women who have experienced false-positive mammograms. Breast Cancer Res Treat 100(2):191–200CrossRefGoogle Scholar
  6. 6.
    Fletcher SW, Elmore JG (2005) False-positive mammograms—can the USA learn from Europe? Lancet. 365(9453):7–8CrossRefGoogle Scholar
  7. 7.
    Porter AJ, Evans EB, Foxcroft LM, Simpson PT, Lakhani SR (2014) Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol 58(1):1–10CrossRefGoogle Scholar
  8. 8.
    Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Nogues C et al (2012) Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 345:e5660CrossRefGoogle Scholar
  9. 9.
    Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998–2005CrossRefGoogle Scholar
  10. 10.
    Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst. 2014;106(6):dju092Google Scholar
  11. 11.
    Jatoi I (2011) The impact of advances in treatment on the efficacy of mammography screening. Prev Med 53(3):103–104CrossRefGoogle Scholar
  12. 12.
    Shapiro S (1997) Periodic screening for breast cancer: the HIP randomized controlled trial. Health Insurance Plan J Natl Cancer Inst Monogr 22:27–30CrossRefGoogle Scholar
  13. 13.
    Jatoi I (2003) Screening clinical breast examination. Surg Clin North Am 83(4):789–801CrossRefGoogle Scholar
  14. 14.
    Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 348:g366CrossRefGoogle Scholar
  15. 15.
    Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW (2015) Effect of mammographic screening from age 40 years on breast cancer mortality in the UK age trial at 17 years’ follow-up: a randomised controlled trial. Lancet Oncol. 16(9):1123–1132CrossRefGoogle Scholar
  16. 16.
    Narod SA (1997) On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet. 349(9068):1846CrossRefGoogle Scholar
  17. 17.
    Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4(4):251–254CrossRefGoogle Scholar
  18. 18.
    Miller AB, To T, Baines CJ, Wall C (2000) Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 92(18):1490–1499CrossRefGoogle Scholar
  19. 19.
    Mittra I (1994) Breast screening: the case for physical examination without mammography. Lancet. 343(8893):342–344CrossRefGoogle Scholar
  20. 20.
    Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, Miller AB, Daniel EE, Gupta S, Uplap P, Thakur MH, Ramani S, Kerkar R, Ganesh B, Shastri SS (2010) A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 126(4):976–984PubMedGoogle Scholar
  21. 21.
    Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, Venugopal M, Anju G, Mathew BS (2011) Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 103(19):1476–1480CrossRefGoogle Scholar
  22. 22.
    Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338(16):1089–1096CrossRefGoogle Scholar
  23. 23.
    Xu X, Gifford-Hollingsworth C, Sensenig R, Shih WH, Shih WY, Brooks AD (2013) Breast tumor detection using piezoelectric fingers: first clinical report. J Am Coll Surg 216(6):1168–1173CrossRefGoogle Scholar
  24. 24.
    Broach RB, Geha R, Englander BS, DeLaCruz L, Thrash H, Brooks AD (2016) A cost-effective handheld breast scanner for use in low-resource environments: a validation study. World J Surg Oncol 14(1):277CrossRefGoogle Scholar
  25. 25.
    Richman IB, Hoag JR, Xu X, Forman HP, Hooley R, Busch SH, et al. Adoption of digital breast tomosynthesis in clinical practice. JAMA Intern Med. 2019Google Scholar
  26. 26.
    Mann RM, Cho N, Moy L. Breast MRI: State of the art. Radiology. 2019:182947Google Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Division of Surgical Oncology and Endocrine SurgeryUniversity of Texas Health and Science CenterSan AntonioUSA

Personalised recommendations